DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

CLEVELAND BIOLABS, INC. (NASDAQ: CBLI)

3.40 0.10 (3.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CBLI $3.40 3.03%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.37
Previous Close $3.30
Daily Range $3.35 - $3.57
52-Week Range $3.05 - $13.80
Market Cap $11.7M
P/E Ratio 5.50
Dividend (Yield) $0.00 (0.0%)
Volume 77,546
Average Daily Volume 48,602
Current FY EPS $0.00

Sector

Healthcare

Industry

Drug Makers

CLEVELAND BIOLABS, INC. (CBLI) Description

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins. Website: http://www.cbiolabs.com/

News & Commentary Rss Feed

Health Care Plunge: 4 Stocks Falling Hard

Cleveland BioLabs Announces Acceptance of Entolimod Phase 1 Study Findings for Poster Presentation a

Cleveland BioLabs Announces Acceptance of Entolimod Phase 1 Study Findings for Poster Presentation at ASCO

Cleveland BioLabs Receives Funding Recommendation From Department of Defense for Additional Developm

Cleveland BioLabs Receives Funding Recommendation From Department of Defense for Additional Development Proposal for Entolimod

Cleveland BioLabs: A Reverse Split Low Floater With Catalysts

Cleveland BioLabs and Incuron Announce Growth of Curaxin CBL0137 Patent Portfolio With U.S. Composit

Cleveland BioLabs and Incuron Announce Growth of Curaxin CBL0137 Patent Portfolio With U.S. Composition of Matter Patent

Cleveland BioLabs' (CBLI) CEO Yakov Kogan on Q4 2014 Results - Earnings Call Transcript

Health Care Sector Update for 02/24/2015: CBLI, STJ, UTHR

Health Care Sector Update for 01/28/2015: CBLI,ABMD,AGIO

3 Stocks Pushing The Drugs Industry Lower

Cleveland BioLabs' (CBLI) CEO Yakov Kogan on Q3 2014 Results - Earnings Call Transcript

Cleveland BioLabs' CEO Presents at FDA Update Conference (Transcript)

See More CBLI News...

CBLI's Top Competitors

CBLI $3.40 (3.03%)
Current stock: CBLI
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB